Search company, investor...

DNA Direct

dnadirect.com

Founded Year

2003

Stage

Acquired | Acquired

Total Raised

$7M

About DNA Direct

DNA Direct delivers guidance and decision support for genomic medicine to patients, providers and payors reducing health risks, preventing disease, and better targeting therapies.

Headquarters Location

Pier 9 Suite 105

San Francisco, California, 94111,

United States

415-646-0222

Missing: DNA Direct's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: DNA Direct's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing DNA Direct

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

DNA Direct is included in 1 Expert Collection, including Omics.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

DNA Direct Frequently Asked Questions (FAQ)

  • When was DNA Direct founded?

    DNA Direct was founded in 2003.

  • Where is DNA Direct's headquarters?

    DNA Direct's headquarters is located at Pier 9, San Francisco.

  • What is DNA Direct's latest funding round?

    DNA Direct's latest funding round is Acquired.

  • How much did DNA Direct raise?

    DNA Direct raised a total of $7M.

  • Who are the investors of DNA Direct?

    Investors of DNA Direct include Medco Health Solutions and Lemhi Ventures.

  • Who are DNA Direct's competitors?

    Competitors of DNA Direct include Adamas Pharmaceuticals, Aegerion Pharmaceuticals, Pearl Therapeutics, Elevation Pharmaceuticals, Satori Pharmaceuticals and 11 more.

Compare DNA Direct to Competitors

L
Link Medicine

Link Medicine is advancing disease-modifying technologies targeted at Alzheimer's, Parkinson's and other neurodegenerative diseases.

C
Cobrek Pharmaceuticals

Cobrek Pharmaceuticals is engaged in the research, development and commercialization of prescription drug therapies, delivery systems and applications that improve quality of life and enhance the lifestyle of patients across the adolescent and adult age-spectrum with particular attention to the needs of the aging population.

A
Advanced Tissue Therapies

Bioceramic Therapeutics Limited is developing new kinds of material that help the body heal itself. The aim is to assist patients, especially the elderly, for whom normal tissue repair mechanisms do not result in possible medical outcomes. Such patients may have fractures or osteoporosis, need orthopedic or periodontal implants or have a condition that has damaged their bones.

I
Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company based in Boston, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to deliver a continuous and consistent flow of medication, and a placement technology including proprietary tools designed to provide an optimal user experience.

T
The DNA Repair Company

The DNA Repair Company was founded to bring recent scientific discoveries from the Dana Farber Cancer Institute and the Massachusetts Institute of Technology to the clinic to benefit cancer patients. Breakthroughs in understanding DNA repair mechanisms have led to new personalized approaches to cancer treatment, beginning with diagnostic tools that improve the efficacy of currently available cancer therapies, as well as drugs under development. DNAR exists to make these tools available to physicians with the goal of improving clinical outcomes.

V
Verva Pharmaceuticals

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.